MARKET

OYST

OYST

OYSTER POINT PHARMA, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

38.05
-0.85
-2.19%
Closed 16:00 02/24 EST
OPEN
38.52
PREV CLOSE
38.90
HIGH
38.90
LOW
37.05
VOLUME
49.51K
TURNOVER
--
52 WEEK HIGH
40.00
52 WEEK LOW
13.26
MARKET CAP
784.30M
P/E (TTM)
-26.5009
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OYST and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OYST stock price target is 33.33 with a high estimate of 40.00 and a low estimate of 25.00.

EPS

OYST News

More
  • Oyster Point Pharma to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020
  • GlobeNewswire · 12h ago
  • Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference
  • GlobeNewswire · 12h ago
  • 70 Biggest Movers From Yesterday
  • Benzinga · 01/29 09:40
  • The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
  • Benzinga · 01/28 14:03

Industry

Biotechnology & Medical Research
-2.96%
Pharmaceuticals & Medical Research
-2.86%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About OYST

Oyster Point Pharma, Inc. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its lead product candidate is OC-01 (varenicline), a selective nicotinic acetylcholine receptor (nAChR) agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease (DED). OC-01’s is a mechanism of action, which is designed to re-establish tear film homeostasis by stimulating the trigeminal nerve, activating the TPP and stimulating the glands and cells responsible for natural tear film production. It is sprayed into the anterior portion of the nasal cavity, and stimulates nAChRs located on the chemosensory endings of the trigeminal nerve resulting in cholinergic neurotransmission.
More

Webull offers kinds of Oyster Point Pharma Inc stock information, including NASDAQ:OYST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OYST stock news, and many more online research tools to help you make informed decisions.